Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (Wei Wang) · 29262574@qq.com · 86+18520529179

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) · Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy) · Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Baltimore, United States

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Pittsburgh, United States · Natal, Brazil

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Squamous Non-small-cell Lung Cancer · Head and Neck Squamous Cell Carcinoma · Cervical Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Scottsdale, United States · Fullerton, United States

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Renal Cell Carcinoma · Non Small Cell Lung Cancer · Melanoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States